Funding Round

Science Corp Closes $230M Series C for Retinal BCI

Science Corporation3/15/2026·03/15/26🌐 USA

Summary

Science Corporation raised $230M in Series C funding for its PRIMA BCI retinal implant and broader neural-interface platform.

Why it matters

Science Corp's $230M Series C is one of the largest BCI funding rounds ever closed, reflecting high confidence in their PRIMA retinal implant which restores functional vision without penetrating the retina. The scale of the round positions them for a 2026–2027 regulatory submission.

#BCI#Industry#Neural Interfaces#Venture Capital

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items — updated daily.

Start free trial

Already a member? Sign in